期刊文献+

转录因子GATA结合蛋白3在家族性阿尔茨海默病发病机制中的作用 被引量:2

The study on the role of transcription factor GATA binding protein 3 in familial Alzheimer' s disease pathogenesis
原文传递
导出
摘要 目的 探讨家族性阿尔茨海默病(Alzheimer's disease,AD)相关的早老素1(presenilin-1,PS-1)V97L突变引起胰岛素降解酶(insulin degrading enzyme,IDE)降低的机制.方法 应用转录因子活性芯片技术检测转录因子活性的差异,再用Western b1ot法验证芯片结果.结果 芯片结合MatInspector软件分析发现,上调了5.5倍的转录因子GATA结合蛋白3(GATA binding protein 3,GATA-3)在IDE启动子上有结合位点,并对IDE起负性调控作用.Westem b1ot也证实稳定转染PS-1 V97L细胞系中GATA-3蛋白表达明显增高.结论 PS-1 V97L突变可能通过上调转录因子GATA-3抑制IDE的表达,影响β-淀粉样蛋白42含量进而参与AD的发生. Objective To investigate the mechanisms of decreasing insulin degrading enzyme (IDE) level by mutation V97L in the gene presenilin 1 (PS-1).Methods Transcription factor GATA binding protein 3 (GATA-3) activity was assessed by protein/DNA array and verified by Western blot in SH-SY5Y cells transfected by PS-1 mutation V97L.Results Protein/DNA array and Western blot revealed that there was increased transcript factor activity (5.5 times high) and protein level of GATA-3 in V97L-PS-1 transfected SH-SY5Y cells.Transcription factor GATA-3 can bind to the IDE promoter and negatively control the IDE transcription level.Conclusion PS-1 mutation V97L may regulate the transcription of IDE via GATA-3, and subsequently involve in deposition of Aβ42 and development of Alzheimer's disease.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2011年第3期159-162,共4页 Chinese Journal of Neurology
基金 基金项目:国家自然科学基金重点资助项目(30830045) 北京自然科学基金面上资助项目(7102071) 北京市教委科技计划重点资助项目(KZ200910025005)
关键词 阿尔茨海默病 早老素1 胰岛素溶酶 GATA3转录因子 Alzheimer disease Presenilin-1 Insulin degrading enzyme GATA3 transcription factor Alzheimer disease Presenilin-1 Insulin degrading enzyme GATA3 transcription factor
  • 相关文献

参考文献23

  • 1Dong MJ,Peng B,Lin XT,et al.The prevalence of dementia in the People's Republic of China:a systematic analysis of 1980-2004 studies.Age Ageing,2007,36:619-624.
  • 2Zhang ZX,Zahner GE,Roman GC,et al.Dementia subtypes in China:prevalence in Beijing,Xi'an,Shanghai,and Chengdu.Arch Neurol,2005,62:447-453.
  • 3张振馨,袁晶.中国阿尔茨海默病所面临的挑战[J].中华神经科杂志,2008,41(6):365-366. 被引量:9
  • 4Estus S,Borchelt D,Kindy MS,et al.Aheta deposition is essential to AD neuropathology.J Alzheimers Dis,2002,4:133-138.
  • 5贾建平,许二赫.家族性阿尔茨海默病的早老素-1基因突变三例报告[J].中华神经科杂志,2003,36(2):102-105. 被引量:11
  • 6Jia J,Xu E,Shao Y,et al.One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer's disease.J Alzheimers Dis,2005,7:119-124.
  • 7Fang B,Jia L,Jia J.Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SYSY neuroblastoma cells.Neurosci Lett,2006,406:33-37.
  • 8Qin W,Jia J.Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42.Eur J Neurosci,2008,27:2425-2432.
  • 9Imam SZ,Jankovic J,Ali SF,et al.Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurrl heterozygous mice.FASEB J,2005,19:1441-1450.
  • 10Blomqvist ME,Chalmers K,Andreasen N,et al.Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.Neurobiol Aging,2005,26:795-802.

二级参考文献18

  • 1汤慈美,刘颖.帕金森病患者的智力和视空间知觉障碍[J].中华老年医学杂志,1993,12(4):200-204. 被引量:13
  • 2洪霞,张振馨,王鲁宁,邵福源,肖世富,王荫华,钱彩韻,舒良,陈生弟,许贤豪.加兰他敏治疗轻中度阿尔茨海默病的随机双盲对照研究[J].中华神经科杂志,2006,39(6):379-382. 被引量:22
  • 3Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer' s disease in the United States and the public health impact of delaying disease onset. Am J Public Health, 1998, 88: 1337- 1342.
  • 4Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol, 2005,62 : 447-453.
  • 5Zhang ZX, Zahner GE, Roman GC, et al. Socio-demographic variation of dementia subtypes in China: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian. Neuroepidemialogy, 2006,27 : 177-187.
  • 6Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet, 2005,366: 2112- 2117.
  • 7Qiu J. Ticking time bomb faced by China' s ageing population. Lancet Neurol, 2007, 6:582-583.
  • 8Zhang ZX. Epidemiology of dementia in China. Neurobiol Aging, 2008,29 : S27-S28.
  • 9Waldemar G, Phung KT, Burns A, et al. Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry, 2007,22:47-54.
  • 10廖瑜,赵帆.家族性阿耳茨海默病八例[J]中华医学遗传学杂志,1994(06).

共引文献18

同被引文献34

  • 1曹雯炜,张丽,钟根龙,李焰生.美国痴呆最新药物治疗临床操作指南[J].中国卒中杂志,2008,3(6):423-429. 被引量:21
  • 2ADI. World Alzheimer Report 2009 [M]. London, UK:Alzheimer ’ s Disease International,2009.
  • 3Ly PT, Wu Y, Zou H,et al. Inhibition of GSK3P-mediatedBACE1 expression reduces Alzheimer-associated phenotypes [J].J Clin Invest,2013,123 :224-235.
  • 4Mouton-Liger F, Paquet C, Dumurgier J, et al. Oxidative stressincreases BACE1 protein levels through activation of the PKR-eIF2a pathway[J]. Biochim Biophys Acta,2012,1822:885-896.
  • 5Piccini A, Borghi R, Guglielmotto M, et al. p-amyloid 1-42induces physiological transcriptional regulation of BACE1 [J]. JNeurochem,2012,122 : 1023-1031.
  • 6Shimizu H,Tosaki A,Kaneko K, et al. Crystal structure of anactive form of BACE1,an enzyme responsible for amyloid betaprotein production[J]. Mol Cell Biol,2008,28 :3663- 3671 .
  • 7Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretasecleavage of Alzheimer ’ s amyloid precursor protein by thetransmembrane aspartic protease BACE [J]. Science, 1999,286 :735-741.
  • 8Masters CL, Selkoe DJ. Biochemistry of amyloid p-protein andamyloid deposits in Alzheimer disease [J]. Cold Spring HarbPerspect Med, 2012, 2:a006262.
  • 9Chu J, Zhuo JM, Praticb D. Transcriptional regulation of p-secretase-1 by 12/15 -lipoxygenase results in enhancedamyloidogenesis and cognitive impairments [J]. Ann Neurol,2012,71:57-67.
  • 10Cruts M, Dermaut B, Rademakers R, et al. Amyloid betasecretase gene (BACE) is neither mutated in nor associated withearly-onset Alzheimer’s disease [J]. Neurosci Lett, 2001,313:105-107.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部